Skip to content
OpenCapital
Get started

Intellia Therapeutics NTLA Prepaid & Other Current

Prepaid & Other Current at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$306.08M+37.5%
ALN
Alnylam PharmaceuticalsALNY
$242.1M+58.8%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$6.58M-46.6%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$55.3M+99.9%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
$12.93M-18.7%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$22.56M+9.5%

Segments

By geography

See full
Tech Square Lease$52.5M+95.9%

Other financials

Income statement

See full
Revenue$15.0M-9.5%
Operating income-$100.5M+16.8%
Net income-$96.2M+15.8%
EPS (diluted)-$0.81+26.4%

Balance sheet

See full
Cash & equivalents$134.7M+6.2%
Total debt$80.5M-32.5%
Total equity$620.9M-20.4%
Total assets$758.8M-23.1%

Cash flow

See full
Operating cash flow-$117.3M+21.2%
CapEx$79.0K-89.3%
Free cash flow-$117.4M+21.5%

Valuation

See full
Market cap$2.17B+106%

Profitability

See full
Operating margin-636.6%-202pp
Net margin-597%-194pp
FCF margin-550.2%-140pp

Returns & leverage

See full
Return on equity-56.3%-1.5pp
Debt / equity0.1×0.0×
Current ratio6.1×+1.2×

Where this comes from

Reported directly by Intellia Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Intellia Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Intellia Therapeutics's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Intellia Therapeutics's prepaid & other current?
Intellia Therapeutics (NTLA) reported prepaid & other current of $81.33M in Q1 2026.
How has Intellia Therapeutics's prepaid & other current changed year-over-year?
Intellia Therapeutics's prepaid & other current increased by 119.0% year-over-year, from $37.14M to $81.33M.
What is the long-term trend for Intellia Therapeutics's prepaid & other current?
Over 5 years (2020 to 2025), Intellia Therapeutics's prepaid & other current has grown at a 32.1% compound annual growth rate (CAGR), from $17.02M to $68.36M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.